(NASDAQ: MBOT) Microbot Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 126.6%.
Microbot Medical's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast MBOT's revenue for 2025 to be $74,239,881, with the lowest MBOT revenue forecast at $74,239,881, and the highest MBOT revenue forecast at $74,239,881.
In 2026, MBOT is forecast to generate $3,097,123,852 in revenue, with the lowest revenue forecast at $3,097,123,852 and the highest revenue forecast at $3,097,123,852.